<i>In Silico</i> evaluation of bioactive compounds as potential inhibitors targeting HIF-1 <i>α</i> /VEGFA/BACE1 pathway against Alzheimer’s disease
<i>In silico</i> screening of potential molecules across different pathogenic pathways in Alzheimer's disease shows promise in developing successful therapeutic methods and continued validation may result in more tailored and safer medicines that address underlying neurodegenerative pathways.
Authors
- Suman Kumar Ray (ORCID: https://orcid.org/0000-0003-2019-962X)
- S. Mukherjee
- Sakshi Rai
Institutions
- All India Institute of Medical Sciences Bhopal (IN)
Publication Details
- Journal
- Journal of Complementary and Integrative Medicine
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1515/jcim-2025-0278
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00